Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)

CAPS Rating: 4 out of 5

A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.

Results 1 - 20 of 73 : 1 2 3 4 Next »

Recs

0
Member Avatar racoveanul (78.71) Submitted: 7/3/2014 11:49:50 AM : Outperform Start Price: $43.38 RDY Score: +18.17

I picked this stock because it is rated 10 by Stockscouter, it has a dividend and a beta computed by Yahoo Finance of more than 1.

Recs

0
Member Avatar drjohn432 (41.85) Submitted: 9/11/2013 12:35:56 AM : Outperform Start Price: $34.76 RDY Score: +29.88

great generic drug maker

Recs

0
Member Avatar IfHeDiesHeDies (75.12) Submitted: 4/8/2013 1:26:54 AM : Outperform Start Price: $33.78 RDY Score: +24.15

A+ awesome growth potential!

Recs

0
Member Avatar pennysplants (99.60) Submitted: 11/22/2012 4:14:34 PM : Outperform Start Price: $12.31 RDY Score: +248.52

Reaffirm long.

Recs

0
Member Avatar immlong (48.16) Submitted: 4/7/2012 1:52:35 AM : Underperform Start Price: $32.69 RDY Score: -13.41

Too much competition in their niche, and nothing pencil to distinguish them.

Recs

0
Member Avatar desidadda (59.64) Submitted: 12/21/2011 9:44:41 PM : Outperform Start Price: $29.12 RDY Score: +17.24

Generics rock

Recs

0
Member Avatar Omen1618 (< 20) Submitted: 10/21/2011 10:57:19 AM : Outperform Start Price: $30.67 RDY Score: +7.32

This company makes generic pharmaceuticals, ton of pharma patents coming due in the near future which provides DRL with a big upside.

Recs

0
Member Avatar dnelyo (< 20) Submitted: 9/10/2011 6:45:58 PM : Outperform Start Price: $29.69 RDY Score: +0.06

India + pharmaceuticals = general guess into demographic growth & spending

Recs

0
Member Avatar 1derway (< 20) Submitted: 5/27/2011 2:24:54 PM : Outperform Start Price: $34.09 RDY Score: +2.35

I always buy generics! What a great company!

next 5 years eps growth 56%
peg .46!!!

Hello!

Recs

0
Member Avatar HardnoseDotCom (70.71) Submitted: 4/25/2011 1:31:30 PM : Outperform Start Price: $36.06 RDY Score: -5.67

low PEG, strong price uptrend

Recs

0
Member Avatar frederick7 (< 20) Submitted: 2/23/2011 12:38:15 PM : Outperform Start Price: $32.65 RDY Score: +5.77

Big money!

Recs

0
Member Avatar modestus1 (< 20) Submitted: 12/27/2010 10:49:56 PM : Outperform Start Price: $35.45 RDY Score: -12.18

One of India's leading generic drug maker with a large market to expand.

Recs

0
Member Avatar dgoldenz (24.18) Submitted: 11/8/2010 10:35:58 AM : Outperform Start Price: $38.25 RDY Score: -27.29

up, up, and away

Recs

0
Member Avatar rogervictor (< 20) Submitted: 10/26/2010 2:16:46 PM : Outperform Start Price: $36.00 RDY Score: -24.12

With the expiration of expensive patten, generic drug manufacturers are bound to prosper. TEVA, andReddy could be the next beneficiaries.

Recs

0
Member Avatar msricekc (78.68) Submitted: 10/13/2010 11:37:57 AM : Outperform Start Price: $13.40 RDY Score: +220.18

I sold too early.

Recs

0
Member Avatar jimrusch22 (39.41) Submitted: 7/26/2010 3:53:37 PM : Outperform Start Price: $26.67 RDY Score: +14.97

rapidy growing globally - as aggressivie a company as TEVA

Recs

0
Member Avatar AmericanGenius (22.76) Submitted: 6/4/2010 11:44:38 AM : Outperform Start Price: $28.58 RDY Score: -2.66

India or Pharm? How about both!

Recs

0
Member Avatar LevGross (65.37) Submitted: 5/28/2010 9:53:01 AM : Outperform Start Price: $27.45 RDY Score: +7.55

Really like this company. Major player in generics in the US and positioned in the country with the biggest growth potential. Buy this and ABB.

Recs

0
Member Avatar sanjay1969 (< 20) Submitted: 5/28/2010 6:25:10 AM : Outperform Start Price: $27.36 RDY Score: +8.62

regarding hydrocarbon industry

Recs

0
Member Avatar jahjimhall (< 20) Submitted: 2/23/2010 2:24:32 PM : Outperform Start Price: $23.08 RDY Score: +41.51

Rising health care utilization in Asia. Expect Rupee to outperform Dollar due to unprecedented USA deficit spending, so this stock will benefit from currency movement also.

Results 1 - 20 of 73 : 1 2 3 4 Next »

Featured Broker Partners


Advertisement